MBB Public Markets I LLC Purchases New Holdings in Solventum Corporation $SOLV

Key Points

• MBB Public Markets I LLC acquired a new stake of 4,072 shares in Solventum Corporation, valued at approximately $310,000, as reported in their 13F filing with the SEC.
• Solventum's shares are currently down 2.3%, with a market capitalization of $12.35 billion and reported a quarterly EPS of $1.69, surpassing estimates.
• Wall Street analysts have mixed ratings on Solventum, with four analysts recommending a buy and a consensus price target of $85.75 for the stock.

MBB Public Markets I LLC purchased a new stake in shares of Solventum Corporation (NYSE:SOLV - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,072 shares of the company's stock, valued at approximately $310,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SOLV. Ameriprise Financial Inc. increased its stake in Solventum by 14.8% during the fourth quarter. Ameriprise Financial Inc. now owns 75,874 shares of the company's stock valued at $5,023,000 after acquiring an additional 9,776 shares during the period. Bank of America Corp DE boosted its holdings in Solventum by 5.1% during the fourth quarter. Bank of America Corp DE now owns 855,690 shares of the company's stock valued at $56,527,000 after purchasing an additional 41,578 shares in the last quarter. Ethic Inc. acquired a new stake in Solventum during the fourth quarter valued at approximately $549,000. Ensign Peak Advisors Inc boosted its holdings in Solventum by 92.3% during the fourth quarter. Ensign Peak Advisors Inc now owns 34,165 shares of the company's stock valued at $2,257,000 after purchasing an additional 16,394 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in Solventum by 2.9% during the fourth quarter. Janus Henderson Group PLC now owns 11,374 shares of the company's stock valued at $752,000 after purchasing an additional 317 shares in the last quarter.

Solventum Stock Down 2.3%

Shares of SOLV opened at $71.25 on Thursday. The company has a market capitalization of $12.35 billion, a P/E ratio of 32.98, a PEG ratio of 2.98 and a beta of 0.53. The company has a debt-to-equity ratio of 2.14, a current ratio of 1.22 and a quick ratio of 0.86. Solventum Corporation has a one year low of $60.70 and a one year high of $85.92. The business's 50 day simple moving average is $73.27 and its 200-day simple moving average is $72.75.

Solventum (NYSE:SOLV - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $1.69 EPS for the quarter, topping the consensus estimate of $1.45 by $0.24. The business had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%.Solventum's revenue was up 3.8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, sell-side analysts predict that Solventum Corporation will post 6.58 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SOLV. Piper Sandler reaffirmed an "overweight" rating and set a $94.00 price objective (up from $87.00) on shares of Solventum in a report on Friday, August 8th. Wall Street Zen downgraded Solventum from a "strong-buy" rating to a "buy" rating in a report on Tuesday. Argus raised Solventum from a "hold" rating to a "buy" rating and set a $90.00 price objective on the stock in a report on Tuesday, July 1st. Morgan Stanley raised Solventum from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $80.00 to $103.00 in a report on Tuesday, July 15th. Finally, Wells Fargo & Company boosted their target price on Solventum from $75.00 to $79.00 and gave the stock an "equal weight" rating in a report on Friday, August 8th. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Solventum has a consensus rating of "Hold" and a consensus price target of $85.75.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Corporation (NYSE:SOLV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.